Browse the evidence

Reduced HRV is a consistent predictor of various diseases, including diabetes, cardiovascular disease, obesity, and psychiatric disorders, and is associated with inflammation and insulin resistance.

Monitor your HRV as a general indicator of your health status. Consistently low HRV may be a sign of underlying issues such as inflammation, insulin resistance, or stress. While not a diagnostic tool on its own, it can help identify individuals at risk for cardiovascular, metabolic, and psychiatric conditions, prompting earlier lifestyle interventions or medical consultation.

Fermentation of dietary fibers by gut bacteria produces short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate, which reduce inflammation, provide energy to colon cells, and regulate metabolism.

Eat fiber-rich foods to feed your gut bacteria, which will produce beneficial short-chain fatty acids that reduce gut inflammation and support colon health.

Moderate or non-excessive alcohol consumption, along with above-median fruit and vegetable intake, are key components driving the mortality-reducing association of the Mediterranean Diet.

To maximize longevity benefits, prioritize high intake of fruits and vegetables, include moderate alcohol if you already drink, and limit meat intake, as higher meat consumption was associated with increased mortality risk in this analysis.

High body mass index (BMI > 25 kg/m²) is a major global health risk factor that has caused a more than 2.5-fold increase in global deaths and disability-adjusted life years (DALYs) between 1990 and 2021, with cardiovascular diseases and diabetes being the leading causes of this burden.

High body mass index (BMI) is a major, modifiable risk factor for serious diseases like heart disease, diabetes, and kidney disease. The global burden of disease from high BMI has more than doubled in 30 years. To protect your health, it is crucial to monitor your BMI and work towards maintaining a healthy weight through sustainable lifestyle changes, as high BMI significantly increases your risk of premature death and disability.

High genetic risk for obesity (high GSBMI) is significantly attenuated by frequent alcohol consumption, meaning daily drinkers experience a much smaller genetic effect on BMI compared to non-drinkers.

If you have a high genetic predisposition to obesity, your drinking habits matter more for your weight than the total amount you drink. Specifically, drinking alcohol frequently (daily) appears to blunt the genetic effect on BMI compared to not drinking or drinking rarely. However, this does not mean alcohol is 'good' for weight loss; it is a specific gene-environment interaction where the genetic risk manifests differently.

Sarcopenia is defined by the loss of muscle mass, strength, and physical function, and its prevalence varies significantly depending on the definition used.

Sarcopenia is a serious condition involving loss of muscle mass, strength, and function. Its diagnosis depends on the specific criteria used, so prevalence rates vary widely.

Higher body mass index (BMI), abdominal fatness (waist circumference), and total body fat mass are associated with a significantly increased risk of developing atrial fibrillation, with risk increasing non-linearly at higher BMI levels.

Maintain a healthy body weight and minimize abdominal fat to lower your risk of atrial fibrillation. This risk increases even within the 'normal' BMI range (starting around 22) and is strongly linked to waist size and total body fat mass, not just obesity. Focus on keeping your waist circumference low and overall fat mass in check, as these are significant, modifiable risk factors for heart rhythm disorders.

Fad diets, supplements, and unproven therapies (e.g., phytotherapics, probiotics for weight loss) are ineffective and potentially harmful for obesity treatment.

Avoid fad diets and unproven supplements (phytotherapics, probiotics, caffeine supplements) for weight loss. They are ineffective and may be harmful. Focus on evidence-based strategies like calorie restriction and behavioral changes.

Obesity is a complex chronic disease driven by biological, behavioral, and environmental factors, not merely a result of personal irresponsibility or lack of willpower.

Stop blaming yourself or others for obesity. It is a chronic disease with biological roots, not a moral failing. Seek healthcare providers who treat it as such, focusing on health outcomes rather than just weight loss.

Different methods of measuring muscle hypertrophy (e.g., ultrasound, DXA, MRI, biopsy) often yield poorly correlated results, making it difficult to determine if true hypertrophy has occurred using a single metric.

Do not rely on a single measurement tool to judge your progress. Ultrasound, DXA, and MRI measure different things (thickness, lean mass, volume) and may not correlate with each other or with actual strength gains. If you are tracking progress, use multiple metrics (strength, visual, maybe one imaging modality) and understand that 'size' is a complex, multi-component adaptation.

Obese individuals with a normal metabolic profile (MHO) have significantly higher risks of heart failure, respiratory diseases, and all-cause mortality compared to non-obese individuals with a normal metabolic profile.

If you have obesity, do not assume you are 'healthy' just because your blood pressure and sugars are normal. You still face higher risks of heart failure and lung disease than someone who is not obese. Weight management is recommended for all people with obesity, regardless of their current metabolic profile, to lower these risks.

PGC-1α is a central regulator of exercise-induced mitochondrial biogenesis, but it is not strictly obligatory as biogenesis can still occur in its absence due to biological redundancy.

While PGC-1α is a key protein involved in building mitochondria, you don't need to worry about 'activating' it specifically. It is naturally upregulated by the stress of exercise. The fact that your body has redundant pathways means that as long as you challenge your muscles with endurance or high-intensity exercise, your body will find a way to build mitochondria, even if one specific pathway is less active.

Bariatric surgery significantly reduces all-cause mortality and mortality from specific chronic diseases (diabetes, CAD, cancer) compared to non-surgical management.

Bariatric surgery not only helps you lose weight but significantly extends your life expectancy by reducing the risk of death from heart disease, diabetes, and cancer. This mortality benefit is unique to surgical weight loss and is not seen with lifestyle-induced weight loss.

Training status (years of experience) and sex do not significantly improve the predictive accuracy of dose-response models for resistance training outcomes.

You do not need to drastically change your core training variables (load, volume) based solely on your sex or years of training experience. Focus on matching load to your specific performance goal.

Obesity is a complex, chronic, multifactorial disease driven by genetic, epigenetic, psychosocial, and microenvironmental factors, rather than solely an energy imbalance.

Stop viewing obesity as a simple failure of willpower or calorie counting. Recognize it as a complex biological disease involving genetics, gut health, and stress. This shifts the focus from self-blame to seeking comprehensive medical and lifestyle interventions that address these underlying drivers.

Current 'exercise mimetic' compounds fail to replicate the broad health benefits of exercise because they target only skeletal muscle pathways, ignoring critical cardiovascular, autonomic, and systemic adaptations.

Do not rely on 'exercise pills' or mimetics for comprehensive health. They currently only affect muscle metabolism and miss crucial cardiovascular and systemic benefits. The most effective strategy remains actual physical activity or, for cardiovascular risk management, evidence-based polypills if exercise is not possible, though even these do not fully replace exercise.

Obesity is an independent proarrhythmic risk factor for both atrial and ventricular arrhythmias, mediated by structural remodeling (atrial/ventricular dilation, epicardial fat infiltration) and electrophysiological changes (prolonged QTc, P-wave dispersion).

Obesity directly increases the risk of heart rhythm problems (atrial and ventricular arrhythmias) through structural changes like heart enlargement and fat infiltration around the heart. This risk exists independently of other conditions like high blood pressure. Weight loss is a key intervention to reduce this risk.

Body Mass Index (BMI) is an inadequate and potentially misleading metric for assessing individual cardiometabolic risk because it fails to account for regional fat distribution and ectopic lipid deposition, which are the true drivers of disease.

Stop using BMI as your primary health metric. Instead, focus on waist circumference and metabolic markers (blood pressure, lipids, glucose). If you have a high BMI but a small waist and good metabolic markers, your risk may be low. Conversely, if you have a normal BMI but a large waist, your risk may be high. Prioritize lifestyle habits (diet quality, physical activity) that reduce visceral fat rather than just total weight.

Exposure to aerial environmental stressors, specifically fine particulate matter (PM2.5) and gaseous pollutants, causes cardiovascular disease and mortality through systemic inflammation, oxidative stress, and autonomic nervous system imbalance.

Monitor local air quality indices (AQI) and smog alerts. On days with high pollution, limit prolonged outdoor exertion, especially near traffic. Consider using air purifiers indoors and keeping windows closed during peak pollution times. This is a modifiable risk factor that acts independently of your diet and exercise habits.

Nutritional supplementation alone does not improve mobility or physical function in older adults when compared to physical activity interventions.

Do not rely on supplements to keep you mobile. While a healthy diet is important, it does not replace the need for physical activity. Focus on exercise groups rather than buying supplements for mobility.

Imaging-based body composition assessment (DXA, CT, or MRI) is required to demonstrate that weight loss from anti-obesity drugs is attributable to fat mass reduction rather than lean mass loss, as mandated by updated US FDA and Korean MFDS guidelines.

If you are taking anti-obesity medication, ask your provider about body composition analysis (DXA or CT) rather than relying solely on weight. This ensures your weight loss is coming from fat stores and not muscle tissue, which is critical for long-term metabolic health and is now a regulatory standard for drug approval.

DXA is the preferred imaging modality for anti-obesity drug trials due to its balance of low radiation, cost-effectiveness, and accessibility, although CT and MRI offer superior precision for visceral fat and muscle quality assessment.

For most obesity drug trials, DXA is the standard imaging tool because it is cheap, safe, and widely available. However, if detailed analysis of visceral fat or muscle quality (myosteatosis) is needed, CT or MRI may be used despite higher costs.

BMI is a valid and necessary tool for population-level surveillance of adiposity and obesity risk, but its use in individual clinical treatment decisions is inappropriate without additional measures.

Use BMI as a general screening tool for population health, not as a definitive diagnosis for individuals. If you are concerned about your health, ask for a comprehensive assessment including metabolic markers, not just a weight-based calculation.

Current hypertension guidelines do not yet recommend incretin-based therapies as first-line treatment because no large-scale trial has used blood pressure reduction as its primary endpoint, despite robust secondary data showing efficacy.

You cannot currently get GLP-1 medications prescribed specifically for high blood pressure as a first-line treatment under standard insurance guidelines. They are primarily approved for diabetes and weight loss. However, if you have both hypertension and obesity/diabetes, your doctor may prescribe them for those conditions, which will incidentally lower your blood pressure significantly.